Work

Type-2 and Allergic Biomarkers in Asthma and/or COPD in the NOVELTY Study

Year: 2025

Type: conference-abstract

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/ajrccm.2025.211.abstracts.a1338

Authors: H. Reddel, A. Mangelis, A. Malinovschi, M. Borres, R. Faner, R. Hughes, H. Müllerová, J.M.M. Olaguíbel, A. Papi, C. Janson, for the NOVELTY Scientific Community and the NOVELTY study investigators

Institutions: The University of Sydney, Woolcock Institute of Medical Research, Sydney Local Health District, Macquarie University, AstraZeneca (United Kingdom), Uppsala University, Thermo Fisher Scientific (Sweden), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, University of Ferrara

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410268951

Cites:

Cited by:

Related to: 10